Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder

Abstract Background Translating innovative research advancements into commercially viable medical interventions presents well-known challenges. However, there is limited understanding of how specific patient, clinical, social, and legal complexities have further complicated and delayed the developme...

詳細記述

書誌詳細

主要な著者:	Matthew P. Heshmatipour, Tyler M. Duvernay, Desislava Z. Hite, Eboo Versi, Michael P. Hite, David F. Reeser, Victor Prikhodko, Ariana M. Nelson, Bina Julian, Milton L. Greenberg
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2025-03-01
シリーズ:	Addiction Science & Clinical Practice
主題:	Opioid use disorder (OUD) Stigma Clinicians Medical devices Therapeutics commercialization
オンライン･アクセス:	https://doi.org/10.1186/s13722-025-00554-1
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!